4.3. Expression and Purification of Recombinant Proteins (E. coli and SF9 Tau)

LD Lisa Diez
LK Larisa E. Kapinos
JH Janine Hochmair
SH Sabrina Huebschmann
AD Alvaro Dominguez-Baquero
AV Amelie Vogt
MR Marija Rankovic
MZ Markus Zweckstetter
RL Roderick Y. H. Lim
SW Susanne Wegmann
request Request a Protocol
ask Ask a question
Favorite

All plasmids were verified by Sanger sequencing prior to protein production. Human Tau isoforms and variants (2N4R, 1N4R, 0N4R, TauRD, N-term) were expressed in E. coli BL21 Star (DE3) (Invitrogen, Waltham, MA, USA) as previously described [37]. Protein expression was induced with 0.5 mM IPTG at OD600 = 0.6 for ~3 h at 37 °C. Cells were harvested, resuspended in lysis buffer (20 mM MES, 1 mM EGTA, 0.2 mM MgCl2, 1 mM PMSF, 5 mM DTT, protease inhibitors (Pierce Protease Inhibitor Mini Tablets, EDTA-free), and lysed using a French press. After initial purification by adding 500 mM NaCl and boiling at 95 °C for 20 min, cell debris was removed by centrifugation and the supernatant was dialyzed against a low salt buffer (Buffer A: 20 mM MES, 50 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 2 mM DTT, 0.1 mM PMSF, pH 6.8), filtered (0.22 µm membrane filter), run through a cation exchange column (HiTrap SP HP, 5 mL, GE Healthcare, Chicago, IL, USA), and eluted with a high salt buffer (Buffer B: 20 mM MES, 1000 mM NaCL, 1 mM MgCl2, 1 mM EGTA, 2 mM DTT, 0.1 mM PMSF, pH 6.8). Fractions containing Tau were pooled, concentrated using spin column concentrators (Pierce Protein concentrators; 10–30 kDa MWCO, Thermo Fischer Scientific, Waltham, MA, USA), and run through a size exclusion column (Superose 6 10/300, GE Healthcare, Chicago, IL, USA). Fractions containing purified monomeric Tau were concentrated as before and buffer exchanged to PBS, 1 mM DTT, pH 7.4. The final Tau concentration was measured with BCA assay (BCA kit, PIERCE), and the protein was stored at −80 °C.

Phosphorylated Tau (P-Tau and P-TauΔK280) was expressed in insect (SF9) cells by infection with a recombinant baculovirus containing a pTriEx-Tau plasmid that encodes human full-length Tau (2N4R or TauΔK280) with a N-terminal Strep-Tag [51]. After cell lysis, the cleared lysate was applied to a 10 mL Strep-Tactin column (Iba) and a gel filtration column (Superdex200 16,600, GE Healthcare, Chicago, IL, USA). The purified protein was stored in PBS containing 1 mM TCEP at −80 °C.

Nup98-FG and Nup98-FG/FS plasmid constructs were bought from GenScript (Piscataway, NJ, USA) and expressed and purified as described before [52]. Briefly, Nup98-FG represents the N-terminal FG-domain of Nup98 (aa 1-498), with one additional cysteine at the N-terminus to facilitate covalent binding to the gold surface of the SPR chip; Nup98-FG/FS is the full F/S mutant of Nup98-FG.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A